{"id":"W4396872898","doi":"10.1182/bloodadvances.2024012880","title":"Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Daiichi Sankyo Europe; National Cancer Institute; Genentech; Servier; Astellas Pharma; Galecto; CTI Biopharma; Taiho Pharmaceutical; Incyte; Astex Pharmaceuticals; Gilead Sciences; GlaxoSmithKline; MorphoSys; Celgene; Bristol-Myers Squibb; AstraZeneca; Pfizer; National Center for Advancing Translational Sciences; Agios Pharmaceuticals","keywords":"Medicine; Internal medicine; Oncology; Venetoclax; Myeloid; Myeloid leukemia; Chemotherapy; Leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000976047,0.0001952107,0.0003540558,0.0001449181,0.00004596607,0.00004035035,0.00008871658,0.00003030236,0.000009395043],"category_scores_gemma":[0.00003957232,0.00009004834,0.00003883063,0.000378094,0.0001398398,0.000191898,0.00002869815,0.0002890715,0.00000308637],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006857128,"about_ca_system_score_gemma":0.0002441381,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001556595,"about_ca_topic_score_gemma":0.00002015441,"domain_scores_codex":[0.9988045,0.0000672934,0.0002288274,0.0003131018,0.0003554195,0.0002309042],"domain_scores_gemma":[0.9994249,0.0001934633,0.00004346781,0.0001922173,0.00007825675,0.00006772432],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001351703,0.004613197,0.6239804,0.0005919429,0.0005494459,0.0001382192,0.005991886,0.00004848604,0.00007880128,0.0008347559,0.00007668892,0.3617445],"study_design_scores_gemma":[0.0529642,0.015332,0.8779672,0.0007112449,0.001118491,0.000133381,0.002798243,0.004862648,0.006724502,0.0003248837,0.03631566,0.000747523],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9891641,0.008365962,0.00006380441,0.0005036301,0.00004786021,0.001099824,0.00006494943,0.00002768035,0.0006622518],"genre_scores_gemma":[0.99727,0.001375167,0.0008703001,0.00004450828,0.000044955,0.0001699797,0.00008180763,0.00001796171,0.000125271],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.360997,"threshold_uncertainty_score":0.3672065,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0218112948476391,"score_gpt":0.3361240990998265,"score_spread":0.3143128042521874,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}